Pediatr. praxi. 2025;26(5):284-288 | DOI: 10.36290/ped.2025.057

Viral hepatitis with emphasis on hepatitis A in the paediatric population

prof. RNDr. Vanda Boštíková, Ph.D., Ing. Hana Střítecká, Ph.D.
Ústav preventivního lékařství, Lékařská fakulta UK v Hradci Králové

Viral hepatitis in children represents a heterogeneous group of diseases caused by different hepatotropic viruses, which differ in the mode of transmission, clinical picture, as well as the risk of possible transition to the chronic stage. Hepatitis A is a very serious public health problem, particularly in the paediatric population. Although this infection does not cause chronic liver disease, it is associated with significant morbidity. In general, the severity of the disease is inversely proportional to the age of the child. In rare cases, fulminant hepatitis may occur and is associated with high mortality. Universal vaccination of children is the most effective method of prevention. Following the introduction of an effective vaccine, the incidence of infection in the United States has decreased by more than 90 %. However, the number of cases is now on the rise again due to large outbreaks in the unvaccinated population. Viral hepatitis in children is an ongoing topic in pediatric practice. Vaccination, education and interdisciplinary collaboration remain the mainstays of effective care for these patients.

Keywords: child population, viral hepatitis, vaccination, hepatitis A, hepatitis B, hepa­titis C, hepatitis D, hepatitis E, nutrition.

Accepted: October 20, 2025; Published: October 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boštíková V, Střítecká H. Viral hepatitis with emphasis on hepatitis A in the paediatric population. Pediatr. praxi. 2025;26(5):284-288. doi: 10.36290/ped.2025.057.
Download citation

References

  1. Rogers ME, Balistreri WF. Viral Hepatitis,Nelson Textbook of Pediatrics: Volume 1-2, Book Chapter. 2024; doi: 10.1016/B978-0-323-88305-4.00406-5. Go to original source...
  2. Shakil S, Akhtar SE. Global paediatric hepatitis outbreak. J Pak Med Assoc. 2023;73(1):228. doi: 10.47391/JPMA.6984.PMID: 36842059. Go to original source... Go to PubMed...
  3. szu.gov.cz.
  4. Multi-country outbreak of hepatitis A in the EU/EEA.
  5. Czech Republic | CGHE. Available from: www.globalhelp.org.
  6. Jonas MM. Viral hepatitis. From prevention to antivirals. Clin Liver Dis. 2000;4(4):849-877. doi: 10.1016/s1089-3261(05)70145-8.PMID: 11232361. Go to original source... Go to PubMed...
  7. Cuthbert JA. Hepatitis A: Old and New Clin Microbiol Rev. 2001;14(1):38-58. doi: 10.1128/CMR.14.1.38-58.2001.PMID: 11148002. Go to original source... Go to PubMed...
  8. Kelly D. Viral hepatitis in children. Adv Exp Med Biol. 2004;549:83-90. doi: 10.1007/978-1-4419-8993-2_12.PMID: 15250519. Go to original source... Go to PubMed...
  9. Merck Manual - Acute Viral Hepatitis: Treatment is supportive; alcohol is forbidden. No special diet or activity restrictions are scientifically justified. Available from: merckmanuals.com.
  10. Weng W. Nutritional characteristics and supportive treatment of hepatitis B-related liver diseases. Dig. Medicine Research. 2020;3:1-12. Go to original source...
  11. MedlinePlus Medical Encyclopedia. Available from: vitamins.medlineplus.govmedlineplus.gov.
  12. Shahramian I. Vitamin E supplementation accelerates normalization of liver enzymes in children with acute hepatitis A (Single-blinded RCT). Arch. Clin. Infect. Dis. 2020; 15(6):e100591. Available from: controls.brieflands.combrieflands.com. Go to original source...
  13. Sasongko H. Omega-3 fatty acids as a potential treatment for acute hepatitis. J. Pharm. Sci. & Clin. Res. 2023;8(2):123-131. Go to original source...
  14. Luo Y. Epigallocatechin-3-gallate (EGCG) in liver diseases. Nutrients, 2025;17(7):1101. Go to original source... Go to PubMed...
  15. Zhang L. Hepatitis A vaccination. Hum Vaccin Immunother. 2020;2:16(7):1565-1573. doi: 10.1080/21645515.2020.1769389. PMID: 32649265. Go to original source... Go to PubMed...
  16. Dentinger CM. Emerging infections: hepatitis A. Am J Nurs. 2009;109(8):29-33. doi: 10.1097/01.NAJ.0000358491.84054.09.PMID: 19641403. Go to original source... Go to PubMed...
  17. Státní veterinární správa. Available from: svscr.cz.
  18. Husa J, Šperl J, Urbánek P, et al. Doporučený postup diagnostiky a léčby chronické hepatitidy D. Vnitř. Lék. 2023;69(8):525-532. doi: 10.36290/vnl.2023.104. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.